Summary
This PRA Insights report focusing on Alzheimer’s disease research was compiled from survey data gathered at the 2017 Alzheimer’s Association International Conference (AAIC). The aim of the survey was to gather insight on clinical development and the future of research in Alzheimer’s disease from pharma and biotech, academic researchers, next generation investigators, clinicians and the care research community involved in the prevention and treatment of Alzheimer’s disease and other dementias.
Register to download
PRA Insights Report: Alzheimer's Disease Research
You may also be interested in:

Mental Health Crisis: The Second Wave of COVID-19
COVID-19 has stopped the world in its tracks. The government-issued stay-at-home orders go against our innate, natural inclination to be social…

Alzheimers Disease Infographic
Alzheimer's Disease is the most common type of dementia accounting for 60%-80% of all cases. In the past 5 years, PRA has conducted numerous clinical…

5 Tips for Healthy Social Distancing
Social distancing is a new term for us all—and now we hear it every day. According to PRA’s Dr. Greg Licholai, Chief Medical Information Officer,…